使

Junhan Pan1, Cong Zhang1,2,3, Huizhen Huang1

  • 1Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.

概括

一个新的4基因风险评分识别了攻击性肝细胞癌 (HCC) 亚型,巨型 (MTM) 和封装瘤集群的血管 (VETC) -HCC. 这一分数预测了预后,并为HCC患者指导了个性化治疗策略.